Clinical and Patient-Reported Outcomes in People Living With HIV on Biktarvy® in Observational BICSTaR Study Demonstrate Consistent Efficacy Profile in Real-World Setting
Go back to Clinical and Patient-Reported Outcomes in People Living With HIV on Biktarvy® in Observational BICSTaR Study Demonstrate Consistent Efficacy Profile in Real-World Setting| Gilead Sciences (NASDAQ: GILD) | Delayed: 146.64 -4.35 (2.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $150.99 | 52 Week High | $108.63 | |||
| Open | $146.98 | 52 Week Low | $71.39 | |||
| Day High | $148.65 | P/E | 81.02 | |||
| Day Low | $145.45 | EPS | $1.81 | |||
| Volume | 6,023,342 | |||||
